![]()
|
Report Date : |
22.06.2007 |
IDENTIFICATION DETAILS
|
Name : |
INTERNATIONAL
ISOTOPES INC. |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
01/11/1995 |
|
|
|
|
Legal Form : |
Corporation -
Public |
|
|
|
|
Line of Business : |
Manufacturer of
nuclear pharmaceutical products and equipment. |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average/normal. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Exists |
IDENTIFICATION &
EXECUTIVE SUMMARY
Company Name: INTERNATIONAL
ISOTOPES INC.
Address:
City:
State/Province:
Zip Code: 83401
Country: UNITED
STATES
Telephone: 208
524-5300
Facsimile: 208
524-1411
In KUSD As of:
31/12/2006
Sales /
Revenue: 4,470
Net Income: -
1,037
Total Equity: 2,223
Number of Employees:
21
Legal Form: Corporation
- Public
Website: www.intisoid.com
Maj.
Shareholder: Mr. John M. McCormack
Business Activity: The Firm is a manufacturer of nuclear
pharmaceutical products and equipment.
NOTE TO CLIENT
NOTE: The provided
address; 2325 WEST BROADWAY SUITE D,
IMPERATIVES
TAKEN FROM THE
FIRM'S 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION FILING:
Credit Facility:
"As of December
31, 2005, we had net borrowings of $699,057 with
LEGAL
Legal Form: Corporation -
Public
Since (D/M/Y): 01/11/1995
State/Province of
Incorporation: TX
Status: ACTIVE
Previous Legal Form:
Company is required
to publish an annual financial report.
The Firm is
incorporated in
Company
Information: INTERNATIONAL ISOTOPES INC
4137 COMMERCE CIR
Status: IN
GOOD STANDING
NOT
FOR DISSOLUTION OR WITHDRAWAL
Through May 15, 2006
Registered
Agent: CURTIS ASHMOS
3400
Registered Agent
Resignation Date:
State of
File Number: 0137545000
Charter/COA
Date: November 1, 1995
Charter/COA
Type: Charter
Taxpayer
Number: 17427638378
----------------------------------------------------------------------
The Firm is
qualified in
INTERNATIONAL
ISOTOPES INC.
Type of
Business: CORPORATION, GENERAL BUSINESS
Status: GOODSTANDING,
ANREPT SENT 02 May 2005
State of
Date of
Origination: 19 Jul 2002
Initial Registered
Agent
STEVE T LAFLIN
Filing Number: C144752
Last Annual
Report: 12 May 2005
-------------------
As of Jun. 21, 2007
Traded Over The
Counter Bulletin Board under the symbol INIS:
US$
Closing Price: $
0.219
52 Weeks
High/Low: $ 0.215 / $ 0.08
Shares
Outstanding: N/A
Market Value: N/A
Managers/Key
Personnel
Mr. Steve
Laflin President & CEO
Mr. John Miller
Radiation Officer
Ms. Sandra Wood Accounts Manager
OWNERS
Mr. John M.
McCormack 26.40% Shareholder
Dr. Ralph M.
Richart 23.80 Shareholder
Mr. William
Nicholson 10.10
Shareholder
Marie Keane &
James J. Keane 7.90
Shareholder
Mr. Walter
O'Hearn 7.30
Shareholder
Mr. Steve T.
Laflin 5.20 Shareholder
Name of
Subsidiary
State
Incorporation
------------------ -------------------
International
Isotopes Idaho Inc.
International
Isotopes Fluorine Products Inc.
International
Isotopes Transportation Services Inc.
Other Affiliates
RadQual LLC
ID
UNITED STATES
BANKS
Texas State Bank
TX
Telephone:
Facsimile:
Account Number:
Account Manager:
SEE IMPERATIVE
SECTION
PAYMENT HISTORY
BUSINESS
DATE LAST PAYMENT CREDIT BALANCE
CUR 1- 31- 61-
CATEGORY
REPTD
---------- ----- ----- ------- --------
-------- --- --- --- --- --- --------
AIR TRANS
07-03 00-00 0000000 19600
19600 99 1
0 0 0
CUST 9 YR
BLDG MATRL 07-05 00-00 VARIED 0
0 0 0
0 0 0
CUST 2 YR
CHEMICALS
07-05 00-00 CREDIT 4500 600
23 0 0
77 0
ELEC EQUIP 07-04 00-00 NET 30 800
100 100 0 0
0 0
FINCL SVCS 07-05 07-04 CONTRCT 1600 200
100 0 0 0
0 CUST 8 YR
FREIGHT
07-04 06-03 VARIED 0 0
0 0 0
0 0
HRDWR DIST 07-05 00-00 VARIED 100
0 0 0 0 0 0
PACKAGING
07-06 00-00 NET 30 100 0
0 0 0
0 0 CUST
7 YR
SAFTY PROD 07-05 00-00 NET 30 1100
0 0 0
0 0 0
CUST 2 YR
TELECOM
07-06 00-00 NET 30 100 100
100 0 0
0 0
TRUCK DLR
07-05 00-00 CONTRCT 7000
0 0 0
0 0 0
AIR TRANS
06-11 00-00 NET 30 0 0
0 0 0
0 0 CUST
7 YR
BUS SERVCS 06-02 06-02 NET 30 0
0 0 0
0 0 0
FINCL SVCS 06-03 05-03 CONTRCT 0 0
0 0 0 0 0
SATSFTRY
FINCL SVCS 06-10 06-07 CONTRCT 0 0
0 0 0
0 0 SATSFTRY
LEASING
04-06 00-00 CONTRCT 100 0
0 0 0
0 0
MED SUPPLY 06-04 00-00 VARIED 1700
1700 91 9
0 0 0
OFFC SUPPL 05-11 05-09 CREDIT 1200
100 100 0 0
0 0 CUST
6 YR
OFFC EQUIP 06-06 06-05 NET 30 400
100 0 0
100 0 0 CUST 1
YR
CURRENT QUARTER 34900 20600
97 1 0
2 0
Payment Trends
INDUSTRY BUSINESS BALANCE
CUR 1- 31- 61-
DATE
CUR DBT DBT $ %
30 60 90 91+
--------
--- --- ---
-------- --- --- --- --- ---
20070600
0 6 2 20600 97
1 0 2 0
20070500
0 6 2 25500 87
13 0 0 0
20070400
0 7 1 24300 95
5 0 0 0
20070300
0 7 3 16500 78
22 0 0 0
20070200
0 7 0 20400 100 0
0 0 0
20070100
0 6 0 10400 100 0
0 0 0
Payment History - Quarterly Averages
BALANCE CUR 1-
31- 61-
QUARTER
YEAR DBT $ %
30 60 90 91+
-------- ------ --- -------- --- --- --- --- ---
First
2007 1 20400 92
8 0 0 0
Fourth
2006 0 11500 100 0
0 0 0
Third
2006 0 14600 100 0
0 0 0
Second
2006 0 9400 98
2 0 0 0
First
2006 0 10200 99 1 0
0 0
FINANCIAL INFORMATION
FINANCIAL FIGURES
Year-End (D/M/Y): 31/03/2007 31/12/2006 31/12/2005
Quarterly Consolidated Consolidated
Sales / Revenues 903 4,470 2,985
Interest Income - 20 5
Gross Margin 374 2,007 1,384
Operating Income (Loss) -547 -864 -818
Interest on Loans 42 193 170
RESULTS
Income before Taxes -519 -1,037 -983
Net Income -519 -1,037 -983
ASSETS
Cash and Equivalents 691 170 185
Inventory 2,659 2,538 2,669
Accounts Receivables 487 353 387
Other Current Assets 82 116 133
Total Current Assets 3,919 3,177 3,374
Property Plant & Equip 2,253 2,176 1,876
Other Fixed Assets - - 292
Total Fixed Assets 2,503 2,427 2,252
Intangibles 71 74 84
Total Assets 6,422 5,604 5,626
LIABILITIES
Trade Creditors 688 645 500
Total Current Liab 1,866 2,410 1,557
Long Term Debt 1,568 969 1,327
Other Long Term Liab 850 - 191
Total Long Term Liab 2,418 969 1,518
Total Liabilities 4,284 3,379 3,075
EQUITY
Retained Earnings -91,352 -90,834 -89,796
Total Equity 2,137 2,223 2,550
FINANCIAL ANALYSIS
Actual Previous Percentage of total assets
31/03/2007 31/12/2006 31/03/2007
31/12/2006
Cash and Equivalents 691 170 10.76 3.03
Inventory
2,659 2,538 41.40 45.29
Other Current Assets 82 116 1.28 2.07
Total Current Assets 3,919 3,177 61.02 56.69
Intangibles 71 74 1.11 1.32
Total Assets 6,422 5,604 100.00
100.00
Total Current Liab 1,866 2,410 29.06 43.00
Long Term Debt 1,568 969 24.42
17.29
Other Long Term Liab 850 0 13.24 0.00
Total Liabilities 4,284 3,379 66.71 60.30
Total Equity 2,137 2,223 33.28 39.67
CURRENT OPERATIONS
NAICS Code: 3254
Pharmaceutical and Medicine Manufacturing
Number of
Employees: 21
Business Activity:
The Firm is a
manufacturer of nuclear pharmaceutical products and equipment. The Firm manufactures patient positioning, and
calibration or operational testing of dose measuring equipment for the nuclear
pharmacy business. These include: flood sources, dose calibrators, rod sources,
flexible and rigid rulers, spot markers, and pen point markers. The Firm also
provides a wide range of teletherapy and experimental irradiator capsules.
TAKEN FROM THE
FIRM'S 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION FILING:
"
purchase
option and a right of first refusal on this property which allows the
Company to purchase this property at any time for a stated amount.
-
PUBLIC RECORD
DEBTOR INFORMATION
Debtor(s): INTERNATIONAL ISOTOPES FLUORINE PRODUCTS,
INC.
4137 COMMERCE CIR.
SECURED PARTY OR
CREDITOR INFORMATION
Secured
Party(s): TEXAS STATE BANK
COLLATERAL INFORMATION
Collateral
Type: ACCOUNT(S) INCLUDING PROCEEDS AND
PRODUCTS
Collateral
Type: INVENTORY INCLUDING PROCEEDS AND
PRODUCTS
Collateral
Type: EQUIPMENT INCLUDING PROCEEDS AND
PRODUCTS
Collateral
Type: MACHINERY INCLUDING PROCEEDS AND
PRODUCTS
Collateral
Type: VEHICLES INCLUDING PROCEEDS AND
PRODUCTS
Collateral
Type: FIXTURES INCLUDING PROCEEDS AND
PRODUCTS
Collateral
Type: BUSINESS MACHINERY/EQUIPMENT
INCLUDING PROCEEDS AND PRODUCTS
--
DEBTOR INFORMATION
Debtor(s): INTERNATIONAL ISOTOPES IDAHO INC
INTERNATIONAL
ISOTOPES INC.
SECURED PARTY OR
CREDITOR INFORMATION
Secured
Party(s): TEXAS STATE BANK
--
No judgements, tax
liens or bankruptcy petitions were traced to the Firm.
GENERAL COMMENTS
The Firm is a well
established manufacturer of nuclear pharmaceutical products and equipment. The
Firm is involved in several legal actions, the result of those action are unclear
as no further information is currently available. The Firm is considered for
normal trade relations.
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)